Notable Call Options Activity in Acorda Therapeutics

Shares of Acorda Therapeutics

are lower on the session by 0.38%, currently trading at $20.93. The stock has been moving largely lower over the past three months and is currently trading below the 50-day moving average. Options traders are focusing on calls today. A short while ago the November 2011 $20.00 call traded 1,500 times on open interest of 20 contracts. Calls are outpacing puts today by 1,000 to 1. Acorda Therapeutics, Inc. is a commercial-stage biopharmaceutical company engaged in the identification, development and commercialization of therapies that improve neurological function in people with multiple sclerosis (

), spinal cord injury, and other disorders of the nervous system.